Last reviewed · How we verify
NCT02938975: URCT
Field Efficacy Of Insecticide Treated Uniforms And Skin Repellents To Reduce Malaria Incidence In Military Personnel On Active Duty In Regions Of Hyperendemicity
Phase 3 trial testing Ultra 30 Insect Repellent Lotion (30% Lipo DEET) in Malaria in 1,500 participants. Status unknown.
1 January 2019
Quick facts
| Lead sponsor | Ifakara Health Institute |
|---|---|
| Phase | Phase 3 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | prevention |
| Enrollment | 1,500 |
| Start date | 1 November 2017 |
| Primary completion | 1 January 2019 |
| Estimated completion | 1 June 2019 |
| Sites | 1 location across Tanzania |
Drugs / interventions tested
- Ultra 30 Insect Repellent Lotion (30% Lipo DEET)
- Permethrin Factory-Treated Army Combat Uniforms
- Placebo lotion — full drug profile →
- Army combat uniform
Conditions studied
- Malaria — all drugs for Malaria →
Sponsor
Ifakara Health Institute
Who can join
Adults 18 to 40, any sex, with Malaria. Healthy volunteers can join.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Incidence of Plasmodium falciparum malaria through monthly measurement of malaria positivity by direct polymerase chain reaction (PCR) to detect parasite DNA
Time frame: Monthly active case detection for 12 months
Blood spots will be collected on Whatman 3 filter paper and processed for PCR detection of parasites
Sponsor's own description
Purpose While there is strong evidence that permethrin treated clothing prevents insect bites there is insufficient evidence from trials to demonstrate a reduction in infections. The evidence that topical insect repellants prevent malaria is more robust, but studies in civilian suffer from poor compliance. It is not known if there is an added benefit from combining the two. The effectiveness of permethrin-treated uniforms with and without DEET lotion are compared in a 2x2 design in Mgambo Jeshi la Kujenga Taifa (JKT) military camp in Tanga region. The four arms are: 1) combined intervention group receiving permethrin treated uniform (PTU) and 30% DEET (diethyl toluamide) liposome formula; 2) permethrin intervention group receiving PTU and placebo lotion; 3) DEET intervention group receiving untreated army combat uniform (ACU) and 30% DEET liposome formula; 4) placebo group receiving untreated ACU and placebo lotion. Both participants and investigators will be blinded to treatment allocation. The outcome measure is the incidence of Plasmodium falciparum malaria infection measured by Polymerase Chain Reaction every month by active case detection.
Publications & conference data
5 peer-reviewed publications reference this trial (live from Europe PMC):
-
Mosquito repellents for malaria prevention.
Maia MF, Kliner M, Richardson M, Lengeler C, et al · · 2018 · cited 67× · PMID 29405263 · DOI 10.1002/14651858.cd011595.pub2 -
Topical repellents for malaria prevention.
Gabaldón Figueira JC, Wagah MG, Adipo LB, Wanjiku C, et al · · 2023 · cited 11× · PMID 37602418 · DOI 10.1002/14651858.cd015422.pub2 -
Effect of interventions to reduce malaria incidence among military personnel on active duty: study protocol for a cluster randomised controlled trial of the impact of etofenprox-treated uniforms, permethrin-treated uniforms and DEET insect repellent.
Msellemu D, Ross A, Temu L, Moshi I, et al · · 2021 · cited 7× · PMID 34802455 · DOI 10.1186/s13063-021-05801-9 -
Multi-omics insights into mosquito insecticide resistance for integrated vector management.
Li J, Wang QY. · · 2026 · PMID 42038460 · DOI 10.7717/peerj.21083 -
Effect of Interventions to Reduce Malaria Incidence Among Military Personnel on Active Duty: Study Protocol for a Cluster Randomised Controlled Trial of the Impact of Etofenprox-treated Uniforms, Permethrin-treated Uniforms and DEET Insect Repellent
Msellemu D, Ross A, Temu L, Moshi I, et al · · 2021 · DOI 10.21203/rs.3.rs-618550/v1
Verify or expand the search:
- PubMed search for NCT02938975
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Malaria
Currently open trials in the same condition.
- NCT07358910 — Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective · recruiting
- NCT07036159 — A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months · Phase 2 · recruiting
- NCT06735209 — First-in-Human PfSPZ-LARC2 Vaccination/CHMI · Phase 1 · active not recruiting
- NCT06854042 — A Study of Oral E1018 in Healthy Adult Participants · Phase 1 · recruiting
- NCT06607003 — Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Cha · Phase 1 · recruiting
Other Ifakara Health Institute trials
Trials by the same sponsor.
- NCT06172686 — In-vivo Transmission Model in Semi-immune Adults · Phase 1 · unknown
- NCT05125133 — Evaluation of Insecticide-treated Eave Nets and Window Screens for Malaria Control in Tanzania. · NA · unknown
- NCT04944966 — Safety and Efficacy of Maytenus Senegalensis for the Treatment of Uncomplicated Malaria · Phase 2 · completed
- NCT01930331 — Safety, Tolerability, Pharmacokinetics and Efficacy of ARCO · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02938975 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ifakara Health Institute
- Last refreshed: 3 June 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02938975.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing